These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 11527416
1. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1. Jiang Y, Xu W, Lu J, He F, Yang X. Biochem Biophys Res Commun; 2001 Sep 07; 286(5):1123-30. PubMed ID: 11527416 [Abstract] [Full Text] [Related]
2. Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma. Ozaki I, Mizuta T, Zhao G, Yotsumoto H, Hara T, Kajihara S, Hisatomi A, Sakai T, Yamamoto K. Cancer Res; 2000 Nov 15; 60(22):6519-25. PubMed ID: 11103822 [Abstract] [Full Text] [Related]
7. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells. Ushio K, Hashimoto T, Kitamura N, Tanaka T. Mol Cancer Res; 2009 Jul 15; 7(7):1179-88. PubMed ID: 19567783 [Abstract] [Full Text] [Related]
12. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Nakamura T, Matsumoto K, Kiritoshi A, Tano Y, Nakamura T. Cancer Res; 1997 Aug 01; 57(15):3305-13. PubMed ID: 9242465 [Abstract] [Full Text] [Related]
13. Establishment of a functional HGF/C-MET autocrine loop in spontaneous transformants of WB-F344 rat liver stem-like cells. Presnell SC, Hooth MJ, Borchert KM, Coleman WB, Grisham JW, Smith GJ. Hepatology; 1998 Nov 01; 28(5):1253-9. PubMed ID: 9794909 [Abstract] [Full Text] [Related]
15. Ets-1 triggers and orchestrates the malignant phenotype of mammary cancer cells within their matrix environment. Furlan A, Vercamer C, Desbiens X, Pourtier A. J Cell Physiol; 2008 Jun 01; 215(3):782-93. PubMed ID: 18181172 [Abstract] [Full Text] [Related]
16. Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation. Nakamura T, Kanda S, Yamamoto K, Kohno T, Maeda K, Matsuyama T, Kanetake H. Oncogene; 2001 Nov 15; 20(52):7610-23. PubMed ID: 11753639 [Abstract] [Full Text] [Related]
17. Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases. Harvey P, Clark IM, Jaurand MC, Warn RM, Edwards DR. Br J Cancer; 2000 Nov 15; 83(9):1147-53. PubMed ID: 11027427 [Abstract] [Full Text] [Related]